Southeast Asset Advisors Inc. Maravai Lifesciences Holdings, Inc. Transaction History

Southeast Asset Advisors Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	SELL	$20.6 - $30.37 $278,388 - $410,420	-13,514 Reduced 12.43%	95,181 $2.43 Million
Q2 2022 Aug 15, 2022	BUY	$26.05 - $37.48 $33,057 - $47,562	1,269 Added 1.18%	108,695 $3.09 Million
Q1 2022 May 13, 2022	BUY	$24.46 - $40.92 $54,570 - $91,292	2,231 Added 2.12%	107,426 $3.79 Million
Q4 2021 Feb 14, 2022	BUY	$35.0 - $45.94 $1.46 Million - $1.92 Million	41,706 Added 65.69%	105,195 $4.41 Million
Q3 2021 Nov 15, 2021	BUY	$36.8 - $60.62 $1.23 Million - $2.03 Million	33,458 Added 111.41%	63,489 $3.12 Million
Q2 2021 Aug 13, 2021	BUY	$32.46 - $45.0 $344,919 - $478,170	10,626 Added 54.76%	30,031 $1.25 Million
Q1 2021 May 13, 2021	BUY	$25.8 - $38.49 $500,649 - $746,898	19,405 New	19,405 $692,000

235

141M

223K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $687M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Southeast Asset Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Southeast Asset Advisors Inc. with notifications on news.